Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Glaceum, explained in plain language.
This study tested a new drug called vutiglabridin in 99 people with early Parkinson's disease. Participants took either the drug or a placebo daily for 24 weeks. The goal was to see if the drug is safe and can help control symptoms like movement problems. The study is complete, b…
Phase 2 • Sponsor: Glaceum • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC